Effects of Iodixanol on Respiratory Functions during Coronary Angiography and the Role of Body Composition
Table 2
Alternations in respiratory functions during CA.
Pulmonary function test
Before CA
At the end of CA
2 hours after CA
Female
Male
Female
Male
Female
Male
FEV1%
103.40 ± 17.79
94.17 ± 18.83
94.96 ± 17.063#
84.45 ± 18.31##
95.20 ± 18.51#
84.25 ± 19.68##
FEV1 (L)
2.21 ± 0.42
2.89 ± 0.87
1.96 ± 0.48##
2.60 ± 0.68#
2.03 ± 0.48#:
2.65 ± 0.77#
FVC%
107.20 ± 19.03
96.57 ± 15.82
99.08 ± 20.56#
88.31 ± 17.96##
99.44 ± 19.69
88.71 ± 17.82##
FVC (L)
2.73 ± 0.57
3.76 ± 0.97
2.45 ± 0.65##
3.39 ± 0.92##
2.53 ± 0.64#
3.52 ± 1.01#
FEF25–75%
83.92 ± 24.30
82.54 ± 24.26
73.24 ± 20.45#
72.11 ± 25.41##
74.48 ± 24.74#
71.85 ± 26.71##
FEF25–75% (L/s)
2.43 ± 0.54
2.81 ± 0.99
2.04 ± 0.63#
2.45 ± 0.88#
2.16 ± 0.67
2.36 ± 0.91#
Pulmonary function tests were statically lower at the end of CA and 2 hours after CA. ;#;##. FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF25–75%: forced expiratory flow between 25% and 75% of FVC.
